Literature DB >> 28857231

Challenges in the development of dopamine D2- and D3-selective radiotracers for PET imaging studies.

Robert H Mach1, Robert R Luedtke2.   

Abstract

The dopamine D2-like receptors (ie, D2/3 receptors) have been the most extensively studied CNS receptor with Positron Emission Tomography (PET). The 3 different radiotracers that have been used in these studies are [11 C]raclopride, [18 F]fallypride, and [11 C]PHNO. Because these radiotracers have a high affinity for both dopamine D2 and D3 receptors, the density of dopamine receptors in the CNS is reported as the D2/3 binding potential, which reflects a measure of the density of both receptor subtypes. Although the development of D2- and D3-selective PET radiotracers has been an active area of research for many years, this by and large presents an unmet need in the area of translational PET imaging studies. This article discusses some of the challenges that have inhibited progress in this area of research and the current status of the development of subtype selective radiotracers for imaging D3 and D2 dopamine receptors with PET.
Copyright © 2017 John Wiley & Sons, Ltd.

Entities:  

Keywords:  D2 receptors; D3 receptors; PET radioligands

Mesh:

Substances:

Year:  2017        PMID: 28857231     DOI: 10.1002/jlcr.3558

Source DB:  PubMed          Journal:  J Labelled Comp Radiopharm        ISSN: 0362-4803            Impact factor:   1.921


  11 in total

Review 1.  Selectivity of probes for PET imaging of dopamine D3 receptors.

Authors:  Robert K Doot; Jacob G Dubroff; Kyle J Labban; Robert H Mach
Journal:  Neurosci Lett       Date:  2018-03-05       Impact factor: 3.046

Review 2.  The role of neuroimaging in Parkinson's disease.

Authors:  Natasha S R Bidesi; Ida Vang Andersen; Albert D Windhorst; Vladimir Shalgunov; Matthias M Herth
Journal:  J Neurochem       Date:  2021-10-03       Impact factor: 5.546

Review 3.  Allosteric Interactions between Adenosine A2A and Dopamine D2 Receptors in Heteromeric Complexes: Biochemical and Pharmacological Characteristics, and Opportunities for PET Imaging.

Authors:  Kavya Prasad; Erik F J de Vries; Philip H Elsinga; Rudi A J O Dierckx; Aren van Waarde
Journal:  Int J Mol Sci       Date:  2021-02-09       Impact factor: 5.923

Review 4.  11C- and 18F-Radiotracers for In Vivo Imaging of the Dopamine System: Past, Present and Future.

Authors:  Michael R Kilbourn
Journal:  Biomedicines       Date:  2021-01-22

5.  Interaction of Ligands for PET with the Dopamine D3 Receptor: In Silico and In Vitro Methods.

Authors:  Chia-Ju Hsieh; Aladdin Riad; Ji Youn Lee; Kristoffer Sahlholm; Kuiying Xu; Robert R Luedtke; Robert H Mach
Journal:  Biomolecules       Date:  2021-04-02

6.  Occurrence of Morpholine in Central Nervous System Drug Discovery.

Authors:  Elena Lenci; Lorenzo Calugi; Andrea Trabocchi
Journal:  ACS Chem Neurosci       Date:  2021-01-18       Impact factor: 4.418

7.  Evaluation of Substituted N-Phenylpiperazine Analogs as D3 vs. D2 Dopamine Receptor Subtype Selective Ligands.

Authors:  Boeun Lee; Michelle Taylor; Suzy A Griffin; Tamara McInnis; Nathalie Sumien; Robert H Mach; Robert R Luedtke
Journal:  Molecules       Date:  2021-05-26       Impact factor: 4.927

8.  [18F]Fluorophenylazocarboxylates: Design and Synthesis of Potential Radioligands for Dopamine D3 and μ-Opioid Receptor.

Authors:  Natascha Nebel; Brigitte Strauch; Simone Maschauer; Roman Lasch; Hannelore Rampp; Stefanie K Fehler; Leonard R Bock; Harald Hübner; Peter Gmeiner; Markus R Heinrich; Olaf Prante
Journal:  ACS Omega       Date:  2017-12-06

9.  [O-methyl-11C]N-(4-(4-(3-Chloro-2-methoxyphenyl)-piperazin-1-yl)butyl)-1H-indole-2-carboxamide ([11C]BAK4-51) Is an Efflux Transporter Substrate and Ineffective for PET Imaging of Brain D₃ Receptors in Rodents and Monkey.

Authors:  Jeih-San Liow; Cheryl L Morse; Shuiyu Lu; Michael Frankland; George L Tye; Sami S Zoghbi; Robert L Gladding; Anver B Shaik; Robert B Innis; Amy H Newman; Victor W Pike
Journal:  Molecules       Date:  2018-10-23       Impact factor: 4.411

10.  Validation of gallbladder absorbed radiation dose reduction simulation: human dosimetry of [18F]fluortriopride.

Authors:  Robert K Doot; Jacob G Dubroff; Joshua S Scheuermann; Kyle J Labban; Jenny Cai; Chia-Ju Hsieh; Shihong Li; Hsiaoju Lee; Erin K Schubert; Catherine Hou; Regan Sheffer; Alexander Schmitz; Kuiying Xu; Robert H Mach
Journal:  EJNMMI Phys       Date:  2018-10-08
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.